Volume 14, Issue 2 (Spring 2025)                   aumj 2025, 14(2): 114-128 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Gorji R, Hassanzadeh S, Ghasemzadeh S, GholamAli Lavasani M. Diagnostic Validity of the Persian version of 3rd edition of the Gilliam Autism Rating Scale (GARS-3). aumj 2025; 14 (2) :114-128
URL: http://aums.abzums.ac.ir/article-1-1888-en.html
1- Dep of Psychology, Faculty of Literature and Humanities Science, Science and Research Branch, Islamic Azad University
2- Department of Psychology, Faculty of Psychology and Education, University of Tehran , Shasanz@ut.ac.ir
3- Department of Psychology, Faculty of Psychology and Education, University of Tehran
Abstract:   (1054 Views)

Introduction: Autism spectrum disorder (ASD) is a prevalent neurodevelopmental disorder, and early diagnosis is crucial for effective interventions. The Gilliam Autism Rating Scale (GARS-3) is a widely used tool for diagnosing ASD.
Methods: This descriptive research aimed to validate the Persian version of GARS-3. The sample consisted of 318 individuals aged 3 to 22 years with ASD, as well as normal, mentally retarded, and deaf individuals. Purposeful sampling was used to select the participants.
Results: The results indicated that the Persian version of GARS-3 has good diagnostic and discriminative ability between individuals with ASD and those without (p < 0.05).
Conclusion: The study recommends using GARS-3 for screening ASD in Iranian children, emphasizing the importance of using DSM-5 diagnostic criteria alongside the scale’s desirable psychometric properties.

Full-Text [PDF 339 kb]   (466 Downloads)    
Type of Study: Research | Subject: Special
Received: 2024/12/27 | Accepted: 2025/02/23 | Published: 2025/03/03

References
1. APA. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC, USA: Arlington va American Psychiatric Association; 2013. 2040 p. [DOI:10.1176/appi.books.9780890425596]
2. Rey GF, Rodríguez JS, Llinares ML, Vicens P, Llauradó CC, Torné MT, et al. A systematic review of instruments for early detection of autism spectrum disorders. International journal of psychology and psychological therapy. 2019;19(1):29-38.
3. Duda M, Daniels J, Wall DP. Clinical Evaluation of a Novel and Mobile Autism Risk Assessment. J Autism Dev Disord. 2016;46(6):1953-61. [DOI:10.1007/s10803-016-2718-4] [PMID] []
4. Gorji R, HassanZadeh S, GhasemZadeh S, GholamAli Lavasani M. Gilliam Autism Rating Scale Psychometric Characteristics Investigation for Diagnosing People as Having Autism in the Iranian Community. Alborz University Medical Journal. 2021;10(4):439-50.
5. Gorji R, Hassanzadeh S, Ghasemzadeh S, Qolamali Lavasani M. Sensitivity and Specificity Gilliam Autism Rating Scale (GARS) in Diagnosis Autism Spectrum Disorders: systematic review. The Neuroscience Journal of Shefaye Khatam. 2020;8(4):80-9. [DOI:10.29252/shefa.8.4.80]
6. Russell G, Stapley S, Newlove‐Delgado T, Salmon A, White R, Warren F, et al. Time trends in autism diagnosis over 20 years: a UK population‐based cohort study. Journal of Child Psychology and Psychiatry. 2022;63(6):674-82. [DOI:10.1111/jcpp.13505] [PMID]
7. Baxter AJ, Brugha T, Erskine HE, Scheurer RW, Vos T, Scott JG. The epidemiology and global burden of autism spectrum disorders. Psychological medicine. 2015;45(3):601-13. [DOI:10.1017/S003329171400172X] [PMID]
8. Onaolapo A, Onaolapo O. Global data on autism spectrum disorders prevalence: A review of facts, fallacies and limitations. Universal Journal of Clinical Medicine. 2017;5(2):14-23. [DOI:10.13189/ujcm.2017.050202]
9. Palinkas LA, Mendon SJ, Hamilton AB. Innovations in mixed methods evaluations. Annual review of public health. 2019;40:423. [DOI:10.1146/annurev-publhealth-040218-044215] [PMID] []
10. Samadi SA, McConkey R. Screening for autism in Iranian preschoolers: contrasting M-CHAT and a scale developed in Iran. Journal of autism and developmental disorders. 2015;45(9):2908-16. [DOI:10.1007/s10803-015-2454-1] [PMID]
11. Little SG, Akin-Little A. Preschool, Early Childhood, and Adolescence. In: Matson JL, editor. Handbook of Assessment and Diagnosis of Autism Spectrum Disorder. Cham: Springer International Publishing; 2016. p. 175-90. [DOI:10.1007/978-3-319-27171-2_10]
12. Andersson GW, Gillberg C, Miniscalco C. Pre-school children with suspected autism spectrum disorders: do girls and boys have the same profiles? Res Dev Disabil. 2013;34(1):413-22. [DOI:10.1016/j.ridd.2012.08.025] [PMID]
13. Durkin MS, Elsabbagh M, Barbaro J, Gladstone M, Happe F, Hoekstra RA, et al. Autism screening and diagnosis in low resource settings: challenges and opportunities to enhance research and services worldwide. Autism Research. 2015;8(5):473-6. [DOI:10.1002/aur.1575] [PMID] []
14. Scahill LD. Gabapentin. In: Volkmar FR, editor. Encyclopedia of Autism Spectrum Disorders. New York, NY: Springer New York; 2013. p. 1391-.
15. Randall M, Egberts KJ, Samtani A, Scholten RJ, Hooft L, Livingstone N, et al. Diagnostic tests for autism spectrum disorder (ASD) in preschool children. Cochrane Database Syst Rev. 2018;7:Cd009044. [DOI:10.1002/14651858.CD009044.pub2] [PMID] []
16. McConachie H, Parr JR, Glod M, Hanratty J, Livingstone N, Oono IP, et al. Systematic review of tools to measure outcomes for young children with autism spectrum disorder. Health Technol Assess. 2015;19(41):1-506. [DOI:10.3310/hta19410] [PMID] []
17. Allen RA, Robins DL, Decker SL. Autism spectrum disorders: Neurobiology and current assessment practices. Psychology in the Schools. 2008;45(10):905-17. [DOI:10.1002/pits.20341]
18. Falkmer T, Anderson K, Falkmer M, Horlin C. Diagnostic procedures in autism spectrum disorders: a systematic literature review. European child & adolescent psychiatry. 2013;22(6):329-40. [DOI:10.1007/s00787-013-0375-0] [PMID]
19. Mazefsky CA, Oswald DP. The discriminative ability and diagnostic utility of the ADOS-G, ADI-R, and GARS for children in a clinical setting. Autism. 2006;10(6):533-49. [DOI:10.1177/1362361306068505] [PMID]
20. Lecavalier L. An evaluation of the Gilliam autism rating scale. Journal of autism and developmental disorders. 2005;35(6):795. [DOI:10.1007/s10803-005-0025-6] [PMID]
21. Gorji R, Hassanzadeh S, Ghasemzadeh S, GholamAli Lavasani M. Sensitivity, Specificity, and Accuracy of the Persian Version of 3rd Edition of the Gilliam Autism Rating Scale (GARS- 3): A Descriptive Study. Journal of Rafsanjan University of Medical Sciences. 2021;20(9):989-1002. [DOI:10.52547/jrums.20.9.989]
22. Minaei A, Nazeri S. Psychometric properties of the Gilliam Autism Rating Scale-Third Edition (GARS-3) in individuals with autism: A pilot study. Journal of Exceptional Children. 2018;18(2):113-22.
23. Keyhani S. Psychometric properties of gilliam autism scaling scale based on DSM5. Tehran: University of Tehran; 2016.
24. Stolte M, Hodgetts S, Smith V. A critical review of outcome measures used to evaluate the effectiveness of comprehensive, community based treatment for young children with ASD. Research in Autism Spectrum Disorders. 2016;23:221-34. [DOI:10.1016/j.rasd.2015.12.009]
25. Hayes J, Ford T, Rafeeque H, Russell G. Clinical practice guidelines for diagnosis of autism spectrum disorder in adults and children in the UK: a narrative review. BMC Psychiatry. 2018;18(1):222. [DOI:10.1186/s12888-018-1800-1] [PMID] []
26. Huerta M, Lord C. Diagnostic evaluation of autism spectrum disorders. Pediatric Clinics of North America. 2012;59(1):103. [DOI:10.1016/j.pcl.2011.10.018] [PMID] []
27. Robinson J. Gilliam Autism Rating Scale (GARS). In: Volkmar FR, editor. Encyclopedia of Autism Spectrum Disorders. New York, NY: Springer New York; 2013. p. 1441-4.

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Alborz University Medical Journal

Designed & Developed by : Yektaweb